Leveraging the Imaging Transmit Pulse to Manipulate Phase-Change Nanodroplets for Contrast-Enhanced Ultrasound
- 25 January 2019
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
- Vol. 66 (4) , 692-700
Abstract
Phase-change perfluorohexane nanodroplets (PFHnDs) are a new class of recondensable sub-micrometer-sized contrast agents that have potential for contrast-enhanced and super-resolution ultrasound imaging with an ability to reach extravascular targets. The PFHnDs can be optically triggered to undergo vaporization, resulting in spatially stationary, temporally transient microbubbles. The vaporized PFHnDs are hyperechoic in ultrasound imaging for several to hundreds of milliseconds before recondensing to their native, hypoechoic, liquid nanodroplet state. The decay of echogenicity, i.e., the dynamic behavior of the ultrasound signal from optically triggered PFHnDs in ultrasound imaging, can be captured using high frame rate ultrasound imaging. We explore the possibility to manipulate the echogenicity dynamics of optically triggered PFHnDs in ultrasound imaging by changing the phase of the ultrasound imaging pulse. Specifically, the ultrasound imaging system was programmed to transmit two imaging pulses with inverse polarities. We show that the imaging pulse phase can affect the amplitude and the temporal behavior of PFHnD echogenicity in ultrasound imaging. The results of this study demonstrate that the ultrasound echogenicity is significantly increased (about 78% improvement) and the hyperechoic timespan of optically triggered PFHnDs is significantly longer (about 4 times) if the nanodroplets are imaged by an ultrasound pulse starting with rarefactional pressure versus a pulse starting with compressional pressure. Our finding has direct and significant implications for contrast-enhanced ultrasound imaging of droplets in applications such as super-resolution imaging and molecular imaging where detection of individual or low-concentration PFHnDs is required.Keywords
Funding Information
- Breast Cancer Research Foundation (BCRF-18-043)
- National Institutes of Health (EB008101, CA158598, CA149740)
This publication has 35 references indexed in Scilit:
- Super-Resolution Ultrasound Imaging in Vivo with Transient Laser-Activated NanodropletsNano Letters, 2016
- Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathologyLaboratory Investigation, 2015
- Characterization of Macrolesions Induced by Myocardial Cavitation-Enabled TherapyIEEE Transactions on Biomedical Engineering, 2014
- Patterning Expression of Regenerative Growth Factors Using High Intensity Focused UltrasoundTissue Engineering Part C: Methods, 2014
- Ultrafast vapourization dynamics of laser-activated polymeric microcapsulesNature Communications, 2014
- Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signaturesPhysics in Medicine & Biology, 2013
- Indocyanine Green-Loaded Photoacoustic Nanodroplets: Dual Contrast Nanoconstructs for Enhanced Photoacoustic and Ultrasound ImagingACS Nano, 2013
- Decafluorobutane as a Phase-Change Contrast Agent for Low-Energy Extravascular Ultrasonic ImagingUltrasound in Medicine & Biology, 2011
- Vaporization of perfluorocarbon droplets using optical irradiationBiomedical Optics Express, 2011
- Ultrasonic characterization of ultrasound contrast agentsMedical & Biological Engineering & Computing, 2009